This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2021
Title: Masahiro Sonoshita: Innovator in Cancer Treatment
Introduction
Masahiro Sonoshita is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of kinase inhibitor compounds. With a total of 2 patents, Sonoshita is recognized for his dedication to advancing medical science.
Latest Patents
Sonoshita's latest patents focus on kinase inhibitor compounds, compositions, and methods of treating cancer. The first patent describes a compound with a specific structure, including various stereoisomers, pharmaceutically acceptable salts, oxides, or solvates. This invention also encompasses compositions containing the compound and outlines a method for treating cancer in a subject. The second patent mirrors the first, emphasizing the same structural components and therapeutic applications.
Career Highlights
Masahiro Sonoshita is affiliated with the Icahn School of Medicine at Mount Sinai, where he conducts his research. His work has been instrumental in developing new therapeutic strategies for cancer treatment, showcasing his commitment to improving patient outcomes.
Collaborations
Some of Sonoshita's notable coworkers include Arvin C Dar and Ross L Cagan. Their collaborative efforts contribute to the innovative research environment at the Icahn School of Medicine.
Conclusion
Masahiro Sonoshita's contributions to cancer treatment through his patented inventions highlight his role as a leading inventor in the medical field. His work continues to inspire advancements in therapeutic approaches for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
